SARS-CoV-2 proteins and anti-COVID-19 drugs induce lytic reactivation of an oncogenic virus
Chen et al. find that SARS-CoV-2 encoded proteins and some anti-COVID-19 drugs can induce lytic reactivation of Kaposi’s sarcoma-associated herpesvirus (KSHV), one of the major human oncogenic viruses. This study suggests that KSHV-positive patients exposed to COVID-19 or undergoing its treatment ma...
Guardado en:
Autores principales: | Jungang Chen, Lu Dai, Lindsey Barrett, Jennifer James, Karlie Plaisance-Bonstaff, Steven R. Post, Zhiqiang Qin |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c4ba9901e2664db29bea3935dc8d1547 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Valpromide Inhibits Lytic Cycle Reactivation of Epstein-Barr Virus
por: Kelly L. Gorres, et al.
Publicado: (2016) -
Structural and electronic determinants of lytic polysaccharide monooxygenase reactivity on polysaccharide substrates
por: T. J. Simmons, et al.
Publicado: (2017) -
Reactive infectious mucocutaneous eruption secondary to SARS-CoV-2
por: C. Yoonhee Ryder, BS, et al.
Publicado: (2021) -
Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV
por: Xiuyuan Ou, et al.
Publicado: (2020) -
Attenuated Negative Feedback in Monocyte-Derived Macrophages From Persons Living With HIV: A Role for IKAROS
por: Celeste Faia, et al.
Publicado: (2021)